In summary, this study found that LAG‐3 was not only expressed in tumor‐infiltrating lymphocytes in NSCLC patients, it was also ectopically expressed in tumor cells, and this expression was associated with TNM staging. The gene discussed is LAG3; the disease is non-small cell lung carcinoma.